 | • レポートコード：MRC2301D003 • 出版社/出版日：Transparency Market Research / 2022年11月18日 • レポート形態：英文、PDF、166ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の市場調査書では、世界の急性腎不全治療市場について調査・分析を行い、序論、仮定・調査手法、市場概要、市場の展望、治療法別（透析療法、支持療法）分析、種類別（腎前性急性腎不全、腎実質性腎不全、腎後性腎不全）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの内容を整理しました。並びに、当書に掲載されている企業情報には、Angion Biomedica Corp、AM-Pharma、Quark Pharmaceuticals, Inc.、Baxter International, Inc.、Fresenius Medical Care AG & Co. KGaA、LG Chem、Asahi Kasei Medical Co., Ltd.、B. Braun Melsungen AGなどが含まれています。 ・序論 ・仮定・調査手法 ・市場概要 ・市場の展望 ・世界の急性腎不全治療市場規模：治療法別 - 透析療法の市場規模 - 支持療法の市場規模 ・世界の急性腎不全治療市場規模：種類別 - 腎前性急性腎不全の市場規模 - 腎実質性腎不全の市場規模 - 腎後性腎不全の市場規模 ・世界の急性腎不全治療市場規模：エンドユーザー別 - 病院における市場規模 - 外来手術センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の急性腎不全治療市場規模：地域別 - 北米の急性腎不全治療市場規模 - ヨーロッパの急性腎不全治療市場規模 - アジア太平洋の急性腎不全治療市場規模 - 中南米の急性腎不全治療市場規模 - 中東・アフリカの急性腎不全治療市場規模 ・競争状況 |
Acute Kidney Injury Treatment Market – Scope of Report
TMR’s report on the global acute kidney injury treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global acute kidney injury treatment market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global acute kidney injury treatment market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the acute kidney injury treatment market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global acute kidney injury treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global acute kidney injury treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global acute kidney injury treatment market.
The report delves into the competitive landscape of the global acute kidney injury treatment market. Key players operating in the global acute kidney injury treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global acute kidney injury treatment market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market acute kidney injury treatment.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Acute Kidney Injury Treatment Market: Market Snapshot
4. Market Overview
4.1. Global Acute Kidney Injury Treatment Market: Overview
4.2. Global Acute Kidney Injury Treatment Market: Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Acute Kidney Injury Treatment Market Revenue Projection, 2017–2031
4.5. Global Acute Kidney Injury Treatment Market Outlook
5. Market Outlook
5.1. Acute Kidney Injury Epidemiology: Overview
5.2. Key Merger and Acquisitions
5.3. Pipeline Analysis
5.4. CCOVID-19 Impact on Industry
6. Global Acute Kidney Injury Treatment Market Analysis, by Treatment
6.1. Key Findings
6.2. Introduction
6.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Treatment
6.4. Global Acute Kidney Injury Treatment Market Value Forecast, by Treatment
6.4.1. Dialysis
6.4.2. Supportive Care
6.5. Global Acute Kidney Injury Treatment Market Analysis, by Treatment
7. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, by Type
7.1. Key Findings
7.2. Introduction
7.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Type
7.4. Global Acute Kidney Injury Treatment Market Value Forecast, by Type
7.4.1. Pre-renal Acute Kidney Injury
7.4.2. Intrinsic Renal Acute Kidney Injury
7.4.3. Post-renal Acute Kidney Injury
7.5. Global Acute Kidney Injury Treatment Market Analysis, by Type
8. Global Acute Kidney Injury Treatment Market Analysis, by End-user
8.1. Key Findings
8.2. Introduction
8.3. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by End-user
8.4. Global Acute Kidney Injury Treatment Market Value Forecast, by End-user
8.4.1. Hospitals
8.4.2. Ambulatory Surgical Centers
8.4.3. Others
8.5. Global Acute Kidney Injury Treatment Market Analysis, by End-user
9. Global Acute Kidney Injury Treatment Market Analysis, by Region
9.1. Global Acute Kidney Injury Treatment Market Scenario, by Country
9.2. Global Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Region
9.3. Global Acute Kidney Injury Treatment Market Value Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Acute Kidney Injury Treatment Market Analysis
10.1. Key Findings
10.2. North America Acute Kidney Injury Treatment Market Overview
10.3. North America Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country
10.4. North America Acute Kidney Injury Treatment Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5. North America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
10.6. North America Acute Kidney Injury Treatment Market Forecast, by Treatment
10.6.1. Dialysis
10.6.2. Supportive Care
10.7. North America Acute Kidney Injury Treatment Market Value Share Analysis, by Type
10.8. North America Acute Kidney Injury Treatment Market Forecast, by Type
10.8.1. Pre-renal Acute Kidney Injury
10.8.2. Intrinsic Renal Acute Kidney Injury
10.8.3. Post-renal Acute Kidney Injury
10.9. North America Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
10.10. North America Acute Kidney Injury Treatment Market Forecast, by End-user
10.10.1. Hospitals
10.10.2. Ambulatory surgical centers
10.10.3. Others
10.11. North America Acute Kidney Injury Treatment Market Attractiveness Analysis
11. Europe Acute Kidney Injury Treatment Market Analysis
11.1. Key Findings
11.2. Europe Acute Kidney Injury Treatment Market Overview
11.3. Europe Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.4. Europe Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
11.4.1. Germany
11.4.2. U.K.
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Rest of Europe
11.5. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
11.6. Europe Acute Kidney Injury Treatment Market Forecast, by Treatment
11.6.1. Dialysis
11.6.2. Supportive Care
11.7. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by Type
11.8. Europe Acute Kidney Injury Treatment Market Forecast, by Type
11.8.1. Pre-renal Acute Kidney Injury
11.8.2. Intrinsic Renal Acute Kidney Injury
11.8.3. Post-renal Acute Kidney Injury
11.9. Europe Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
11.10. Europe Acute Kidney Injury Treatment Market Forecast, by End-user
11.10.1. Hospitals
11.10.2. Ambulatory Surgical Centers
11.10.3. Others
11.11. Europe Acute Kidney Injury Treatment Market Attractiveness Analysis
12. Asia Pacific Acute Kidney Injury Treatment Market Analysis
12.1. Key Findings
12.2. Asia Pacific Acute Kidney Injury Treatment Market Overview
12.3. Asia Pacific Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.4. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
12.4.1. China
12.4.2. India
12.4.3. Japan
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
12.6. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Treatment
12.6.1. Dialysis
12.6.2. Supportive Care
12.7. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by Type
12.8. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by Type
12.8.1. Pre-renal Acute Kidney Injury
12.8.2. Intrinsic Renal Acute Kidney Injury
12.8.3. Post-renal Acute Kidney Injury
12.9. Asia Pacific Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
12.10. Asia Pacific Acute Kidney Injury Treatment Market Forecast, by End-user
12.10.1. Hospitals
12.10.2. Ambulatory Surgical Centers
12.10.3. Others
12.11. Asia Pacific Acute Kidney Injury Treatment Market Attractiveness Analysis
13. Latin America Acute Kidney Injury Treatment Market Analysis
13.1. Key Findings
13.2. Latin America Acute Kidney Injury Treatment Market Overview
13.3. Latin America Acute Kidney Injury Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.4. Latin America Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of Latin America
13.5. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
13.6. Latin America Acute Kidney Injury Treatment Market Forecast, by Treatment
13.6.1. Dialysis
13.6.2. Supportive Care
13.7. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by Type
13.8. Latin America Acute Kidney Injury Treatment Market Forecast, by Type
13.8.1. Pre-renal Acute Kidney Injury
13.8.2. Intrinsic Renal Acute Kidney Injury
13.8.3. Post-renal Acute Kidney Injury
13.9. Latin America Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
13.10. Latin America Acute Kidney Injury Treatment Market Forecast, by End-user
13.10.1. Hospitals
13.10.2. Ambulatory Surgical Centers
13.10.3. Others
13.11. Latin America Acute Kidney Injury Treatment Market Attractiveness Analysis
14. Middle East & Africa Acute Kidney Injury Treatment Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Acute Kidney Injury Treatment Market Overview
14.3. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Country/Sub-region
14.4. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Country/Sub-region
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of Middle East and Africa
14.5. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Treatment
14.6. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Treatment
14.6.1. Dialysis
14.6.2. Supportive Care
14.7. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by Type
14.8. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by Type
14.8.1. Pre-renal Acute Kidney Injury
14.8.2. Intrinsic Renal Acute Kidney Injury
14.8.3. Post-renal Acute Kidney Injury
14.9. Middle East & Africa Acute Kidney Injury Treatment Market Value Share Analysis, by End-user
14.10. Middle East & Africa Acute Kidney Injury Treatment Market Forecast, by End-user
14.10.1. Hospitals
14.10.2. Ambulatory Surgical Centers
14.10.3. Others
14.11. Middle East & Africa Acute Kidney Injury Treatment Market Attractiveness Analysis
15. Competition Landscape
15.1. Acute Kidney Injury Treatment Market Share Analysis, by Company, 2021
15.2. Competition Matrix
15.3. Company Profiles
15.3.1. Angion Biomedica Corp
15.3.1.1. Company Details
15.3.1.2. Business Overview
15.3.1.3. Financial Overview
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. AM-Pharma
15.3.2.1. Company Details
15.3.2.2. Business Overview
15.3.2.3. Financial Overview
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. Quark Pharmaceuticals, Inc.
15.3.3.1. Company Details
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. Baxter International, Inc.
15.3.4.1. Company Details
15.3.4.2. Business Overview
15.3.4.3. Financial Overview
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
15.3.5. Fresenius Medical Care AG & Co. KGaA
15.3.5.1. Company Details
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. LG Chem
15.3.6.1. Company Details
15.3.6.2. Business Overview
15.3.6.3. Financial Overview
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. Asahi Kasei Medical Co., Ltd.
15.3.7.1. Company Details
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
15.3.8. B. Braun Melsungen AG
15.3.8.1. Company Details
15.3.8.2. Business Overview
15.3.8.3. Financial Overview
15.3.8.4. Strategic Overview
15.3.8.5. SWOT Analysis